Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2005 Mar;64(Suppl 2):ii83–ii86. doi: 10.1136/ard.2004.030791

Psoriasis treatment: traditional therapy

M Lebwohl, P Ting, J Koo
PMCID: PMC1766882  PMID: 15708945

Abstract

Even before the recent development of biological agents, a long list of effective treatments has been available for patients with psoriasis. Topical therapies such as corticosteroids, vitamin D analogues, and retinoids are used for localised disease. Phototherapy including broadband ultraviolet B (UVB), narrowband UVB, PUVA, and climatotherapy are effective for more extensive disease. Systemic therapies such as methotrexate, retinoids, and ciclosporin are effective for patients with refractory or extensive cutaneous disease.

Full Text

The Full Text of this article is available as a PDF (55.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abels D. J., Rose T., Bearman J. E. Treatment of psoriasis at a Dead Sea dermatology clinic. Int J Dermatol. 1995 Feb;34(2):134–137. doi: 10.1111/j.1365-4362.1995.tb03599.x. [DOI] [PubMed] [Google Scholar]
  2. Andreassi L., Giannetti A., Milani M., Scale Investigators Group Efficacy of betamethasone valerate mousse in comparison with standard therapies on scalp psoriasis: an open, multicentre, randomized, controlled, cross-over study on 241 patients. Br J Dermatol. 2003 Jan;148(1):134–138. doi: 10.1046/j.1365-2133.2003.04950.x. [DOI] [PubMed] [Google Scholar]
  3. Bruner Christine R., Feldman Steven R., Ventrapragada Madhuri, Fleischer Alan B., Jr A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J. 2003 Feb;9(1):2–2. [PubMed] [Google Scholar]
  4. Cornell R. C., Stoughton R. B. Correlation of the vasoconstriction assay and clinical activity in psoriasis. Arch Dermatol. 1985 Jan;121(1):63–67. [PubMed] [Google Scholar]
  5. Coven T. R., Burack L. H., Gilleaudeau R., Keogh M., Ozawa M., Krueger J. G. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol. 1997 Dec;133(12):1514–1522. [PubMed] [Google Scholar]
  6. Coven T. R., Walters I. B., Cardinale I., Krueger J. G. PUVA-induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatol Photoimmunol Photomed. 1999 Feb;15(1):22–27. doi: 10.1111/j.1600-0781.1999.tb00048.x. [DOI] [PubMed] [Google Scholar]
  7. Ellison J. A., Patel L., Ray D. W., David T. J., Clayton P. E. Hypothalamic-pituitary-adrenal function and glucocorticoid sensitivity in atopic dermatitis. Pediatrics. 2000 Apr;105(4 Pt 1):794–799. doi: 10.1542/peds.105.4.794. [DOI] [PubMed] [Google Scholar]
  8. Feldman S. R., Sangha N., Setaluri V. Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. J Am Acad Dermatol. 2000 Jun;42(6):1017–1020. [PubMed] [Google Scholar]
  9. Goa K. L. Clinical pharmacology and pharmacokinetic properties of topically applied corticosteroids. A review. Drugs. 1988;36 (Suppl 5):51–61. doi: 10.2165/00003495-198800365-00011. [DOI] [PubMed] [Google Scholar]
  10. Gorham H. Treatment of psoriatic arthropathy by PUVA. Physiotherapy. 1980 Feb;66(2):40–40. [PubMed] [Google Scholar]
  11. Gupta G., Long J., Tillman D. M. The efficacy of narrowband ultraviolet B phototherapy in psoriasis using objective and subjective outcome measures. Br J Dermatol. 1999 May;140(5):887–890. doi: 10.1046/j.1365-2133.1999.02820.x. [DOI] [PubMed] [Google Scholar]
  12. Haagsma C. J. Clinically important drug interactions with disease-modifying antirheumatic drugs. Drugs Aging. 1998 Oct;13(4):281–289. doi: 10.2165/00002512-199813040-00004. [DOI] [PubMed] [Google Scholar]
  13. Kaidbey K., Kopper S. C., Sefton J., Gibson J. R. A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy. Int J Dermatol. 2001 Jul;40(7):468–471. doi: 10.1046/j.1365-4362.2001.01234.x. [DOI] [PubMed] [Google Scholar]
  14. Klinkhoff A. V., Gertner E., Chalmers A., Gladman D. D., Stewart W. D., Schachter G. D., Schachter R. K. Pilot study of etretinate in psoriatic arthritis. J Rheumatol. 1989 Jun;16(6):789–791. [PubMed] [Google Scholar]
  15. Larsen F. G., Jakobsen P., Knudsen J., Weismann K., Kragballe K., Nielsen-Kudsk F. Conversion of acitretin to etretinate in psoriatic patients is influenced by ethanol. J Invest Dermatol. 1993 May;100(5):623–627. doi: 10.1111/1523-1747.ep12472293. [DOI] [PubMed] [Google Scholar]
  16. Lebwohl M., Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001 Oct;45(4):487–502. doi: 10.1067/mjd.2001.117046. [DOI] [PubMed] [Google Scholar]
  17. Lebwohl M., Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001 Nov;45(5):649–664. doi: 10.1067/mjd.2001.117047. [DOI] [PubMed] [Google Scholar]
  18. Lebwohl M., Drake L., Menter A., Koo J., Gottlieb A. B., Zanolli M., Young M., McClelland P. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol. 2001 Oct;45(4):544–553. doi: 10.1067/mjd.2001.116347. [DOI] [PubMed] [Google Scholar]
  19. Lebwohl M., Ellis C., Gottlieb A., Koo J., Krueger G., Linden K., Shupack J., Weinstein G. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol. 1998 Sep;39(3):464–475. doi: 10.1016/s0190-9622(98)70325-1. [DOI] [PubMed] [Google Scholar]
  20. Lebwohl Mark, Quijije John, Gilliard Jean, Rollin Thierry, Watts Oliver. Topical calcitriol is degraded by ultraviolet light. J Invest Dermatol. 2003 Sep;121(3):594–595. doi: 10.1046/j.1523-1747.2003.12421.x. [DOI] [PubMed] [Google Scholar]
  21. Patel B., Siskin S., Krazmien R., Lebwohl M. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol. 1998 Jun;38(6 Pt 1):1010–1011. doi: 10.1016/s0190-9622(98)70171-9. [DOI] [PubMed] [Google Scholar]
  22. Perry H. O., Soderstrom C. W., Schulze R. W. The Goeckerman treatment of psoriasis. Arch Dermatol. 1968 Aug;98(2):178–182. [PubMed] [Google Scholar]
  23. Pittelkow M. R., Perry H. O., Muller S. A., Maughan W. Z., O'Brien P. C. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol. 1981 Aug;117(8):465–468. [PubMed] [Google Scholar]
  24. Piérard G. E., Piérard-Franchimont C., Ben Mosbah T., Arrese Estrada J. Adverse effects of topical corticosteroids. Acta Derm Venereol Suppl (Stockh) 1989;151:26–52. [PubMed] [Google Scholar]
  25. Roenigk H. H., Jr, Auerbach R., Maibach H., Weinstein G., Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol. 1998 Mar;38(3):478–485. doi: 10.1016/s0190-9622(98)70508-0. [DOI] [PubMed] [Google Scholar]
  26. Schiffner R., Schiffner-Rohe J., Wölfl G., Landthaler M., Glässl A., Walther T., Hofstädter F., Stolz W. Evaluation of a multicentre study of synchronous application of narrowband ultraviolet B phototherapy (TL-01) and bathing in Dead Sea salt solution for psoriasis vulgaris. Br J Dermatol. 2000 Apr;142(4):740–747. doi: 10.1046/j.1365-2133.2000.03420.x. [DOI] [PubMed] [Google Scholar]
  27. Scott L. J., Dunn C. J., Goa K. L. Calcipotriol ointment. A review of its use in the management of psoriasis. Am J Clin Dermatol. 2001;2(2):95–120. doi: 10.2165/00128071-200102020-00008. [DOI] [PubMed] [Google Scholar]
  28. Stern R. S., Liebman E. J., Väkevä L. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study. J Natl Cancer Inst. 1998 Sep 2;90(17):1278–1284. doi: 10.1093/jnci/90.17.1278. [DOI] [PubMed] [Google Scholar]
  29. Stern R. S., Nichols K. T., Väkevä L. H. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. N Engl J Med. 1997 Apr 10;336(15):1041–1045. doi: 10.1056/NEJM199704103361501. [DOI] [PubMed] [Google Scholar]
  30. Trehan Manju, Taylor Charles R. Medium-dose 308-nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol. 2002 Nov;47(5):701–708. doi: 10.1067/mjd.2002.125075. [DOI] [PubMed] [Google Scholar]
  31. van Ede A. E., Laan R. F., Rood M. J., Huizinga T. W., van de Laar M. A., van Denderen C. J., Westgeest T. A., Romme T. C., de Rooij D. J., Jacobs M. J. Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2001 Jul;44(7):1515–1524. doi: 10.1002/1529-0131(200107)44:7<1515::AID-ART273>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES